[Skip to Content]
[Skip to Content Landing]

May 2019 - April 2016

Decade

Year

Issue

November 2017, Vol 2, No. 11, Pages 1173-1284

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1173. doi:10.1001/jamacardio.2016.3674
Original Investigation

Long-term Outcomes of Multiple Arterial Coronary Artery Bypass Grafting: A Population-Based Study of Patients in British Columbia, Canada

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1187-1196. doi:10.1001/jamacardio.2017.3705

This population-based study compares the safety and long-term outcomes of multiple arterial grafting vs left internal thoracic artery supplemented by saphenous vein grafts among overall and selected subgroups of patients.

Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial

Abstract Full Text
free access has active quiz has audio
JAMA Cardiol. 2017;2(11):1197-1206. doi:10.1001/jamacardio.2017.3306

This analysis of data from the PARTNER Trial determines the midterm hemodynamic performance of balloon-expandable transcatheter heart valves.

Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1208-1216. doi:10.1001/jamacardio.2017.3425

This analysis of the PARTNER II trial examines the incidence, evolution, and effect on 1-year outcomes of paravalvular regurgitation following transcatheter aortic valve replacement with a third-generation balloon-expandable transcatheter heart valve.

Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1217-1225. doi:10.1001/jamacardio.2017.3451

This study evaluates patient access to PCSK9 inhibitors among those prescribed therapy.

Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1226-1235. doi:10.1001/jamacardio.2017.3471

This study describes temporal trends in bystander cardiopulmonary resuscitation and first-responder defibrillation for out-of-hospital cardiac arrests stratified by home vs public location and their association with survival and neurological outcomes.

Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1236-1246. doi:10.1001/jamacardio.2017.3145

This community-based cohort study of Framingham Heart Study participants applies unsupervised machine learning to define the distribution and prognostic importance of computed tomography–based multiorgan phenotypes associated with adverse health outcomes.

Association of Mitochondrial DNA Copy Number With Cardiovascular Disease

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1247-1255. doi:10.1001/jamacardio.2017.3683

This cohort study determines whether mitochondrial DNA copy number, measured in an easy accessible tissue (buffy coat/circulating leukocytes), is associated with improved risk classification for cardiovascular disease and help guide initiation of statin therapy for primary prevention of cardiovascular disease.

Brief Report

Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non–African American Women

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1256-1260. doi:10.1001/jamacardio.2017.3574

This cohort study compares the clinical characteristics, presentation, and outcomes of peripartum cardiomyopathy between African American and non–African American women.

Research Letter

Targeting the Correct Population When Designing Transitional Care Programs for Medicare Patients Hospitalized With Heart Failure

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1274-1275. doi:10.1001/jamacardio.2017.3089

This study uses data from a large academic medical center to estimate the accuracy of the criteria used by Medicare to represent the burden of hospitalizations for heart failure.

Administrative Codes for Capturing In-Hospital Cardiac Arrest

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1275-1277. doi:10.1001/jamacardio.2017.2904

This study uses linked data from Get With the Guidelines–Resuscitation and Medicare claims to assess the challenges of using administrative billing data to conduct research on 56678 patients with confirmed in-hospital cardiac arrest.

Postmarketing Adverse Events Related to the CardioMEMS HF System

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1277-1279. doi:10.1001/jamacardio.2017.3791

This analysis of postmarketing data related to a wireless pulmonary artery sensor finds approximately 2.8% of patients experience adverse events.

Viewpoint

The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines

Abstract Full Text
JAMA Cardiol. 2017;2(11):1175-1176. doi:10.1001/jamacardio.2017.2543

This Viewpoint discusses the benefit model vs risk-based prevention strategies for cardiovascular disease.

MACRA and Cardiology—The Devil Is in the Details

Abstract Full Text
JAMA Cardiol. 2017;2(11):1177-1178. doi:10.1001/jamacardio.2017.2412

This Viewpoint discusses the implications of the Medicare Access and CHIP Reauthorization Act of 2015 on cardiologists.

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results

Abstract Full Text
JAMA Cardiol. 2017;2(11):1179-1180. doi:10.1001/jamacardio.2017.2922

This Viewpoint discusses how different measures of treatment effect for cardiovascular trials are interpreted for evidence-based communication and their caveats.

From the Heart

Burnout—There’s an App for That: Helping Physicians Deal With Job-Related Stress

Abstract Full Text
JAMA Cardiol. 2017;2(11):1185-1186. doi:10.1001/jamacardio.2017.1758
Editorial

Author Relationships With Industry: Policies and Procedures for Authors and Editors of JAMA Cardiology

Abstract Full Text
JAMA Cardiol. 2017;2(11):1181-1182. doi:10.1001/jamacardio.2017.3461

Improving Outcomes After Out-of-Hospital Cardiac Arrest

Abstract Full Text
JAMA Cardiol. 2017;2(11):1183-1184. doi:10.1001/jamacardio.2017.3472
Invited Commentary

Will Transcatheter Aortic Valve Replacement Echo Surgical Aortic Valve Replacement Durability?

Abstract Full Text
has audio
JAMA Cardiol. 2017;2(11):1206-1207. doi:10.1001/jamacardio.2017.3307

Poor Outcomes in Poor Patients?Peripartum Cardiomyopathy—Not Just Black and White

Abstract Full Text
JAMA Cardiol. 2017;2(11):1261-1262. doi:10.1001/jamacardio.2017.3605

When Should Patients Be Involved in Cardiovascular Clinical Trial Design?Always, Early, and Often

Abstract Full Text
JAMA Cardiol. 2017;2(11):1269-1270. doi:10.1001/jamacardio.2017.3607
Special Communication

Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial Design

Abstract Full Text
JAMA Cardiol. 2017;2(11):1263-1269. doi:10.1001/jamacardio.2017.3606

This article examines successful methods that have been used by researchers to engage patients, caregivers, and the broader health care community in the research process and offers examples of currently funded studies that have fully engaged key stakeholders.

JAMA Cardiology Clinical Challenge

Chest Pain and Shortness of Breath After a Heart Transplant

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2017;2(11):1271-1272. doi:10.1001/jamacardio.2017.2337

A 34-year-old man with a history of ischemic cardiomyopathy that required a heart transplant presented to the hospital with shortness of breath. What would you do next?

Comment & Response

Pharmacists as Integral Members of the Cardiovascular Team

Abstract Full Text
JAMA Cardiol. 2017;2(11):1279-1280. doi:10.1001/jamacardio.2017.2795

Pharmacists as Integral Members of the Cardiovascular Team—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(11):1280. doi:10.1001/jamacardio.2017.2798

Vitamin D Supplementation and Cardiovascular Disease Risk

Abstract Full Text
JAMA Cardiol. 2017;2(11):1280-1281. doi:10.1001/jamacardio.2017.2935

Vitamin D Supplementation and Cardiovascular Disease Risk

Abstract Full Text
JAMA Cardiol. 2017;2(11):1281-1282. doi:10.1001/jamacardio.2017.2938

Vitamin D Supplementation and Cardiovascular Disease Risk—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(11):1282. doi:10.1001/jamacardio.2017.2941

Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy

Abstract Full Text
JAMA Cardiol. 2017;2(11):1282-1283. doi:10.1001/jamacardio.2017.3259

Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(11):1283-1284. doi:10.1001/jamacardio.2017.3221
Correction

Error in Byline

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1284. doi:10.1001/jamacardio.2017.3763

Error in Conflicts of Interest Disclosures

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1284. doi:10.1001/jamacardio.2017.3855
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(11):1174. doi:10.1001/jamacardio.2016.3675
×